DNLI (DNLI) Stock Price & Analysis
DNLI (DNLI) rose 0.00% to USD 23.11 as of July 25, 2026 at 03:06 UTC, according to Nexqual real-time market data.
DNLI last closed at USD 23.11; the session ranged USD 22.67–23.52 on volume of 1,129,603 shares. Market capitalization is —, with a 52-week range of USD 12.58–27.3 (NMS). Source: Nexqual, July 25, 2026 at 03:06 UTC.
Key Statistics (as of July 25, 2026 at 03:06 UTC)
| Price | USD 23.11 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 23.11 |
| Open | USD 23.11 |
| Day Range | USD 22.67 – 23.52 |
| 52-Week Range | USD 12.58 – 27.3 |
| Volume | 1,129,603 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (DNLI)
Nexqual's technical model rates DNLI "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 03:06 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49.29 (neutral) |
| vs SMA50 | Above (USD 22.41) |
| MACD | 0.06 (positive) |
From DNLI's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ALEC | Alector, Inc. | USD 1.48 | ▼ 3.27% |
| RARE | Ultragenyx Pharmaceutical Inc. | USD 26.9 | ▼ 2.69% |
| ARVN | Arvinas, Inc. | USD 8.03 | ▼ 2.78% |
| BBIO | BridgeBio Pharma, Inc. | USD 84.02 | ▲ 1.65% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 83.73 | ▲ 0.01% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:06 UTC. This page is informational and not investment advice.